Continuum Advisory, LLC Becton Dickinson & CO Transaction History

Continuum Advisory, LLC

$773 Million
Q2 2025

A detailed history of Continuum Advisory, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Continuum Advisory, LLC holds 1,262 shares of BDX stock, worth $242,972. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,262

Previous 2,131 40.78%

Holding current value

$242,972

Previous $488,000 55.53%

% of portfolio

0.03%

Previous 0.07%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$165.15 - $226.42 $143,515 - $196,758	-869 Reduced 40.78%	1,262 $217,000
Q1 2025 Apr 22, 2025	BUY	$222.79 - $249.08 $93,571 - $104,613	420 Added 24.55%	2,131 $488,000
Q4 2024 Feb 14, 2025	BUY	$220.02 - $243.75 $97,028 - $107,493	441 Added 34.72%	1,711 $388,000
Q3 2024 Nov 15, 2024	BUY	$221.47 - $242.41 $238,744 - $261,317	1,078 Added 561.46%	1,270 $306,000
Q2 2024 Jul 19, 2024	BUY	$225.07 - $246.17 $1,800 - $1,969	8 Added 4.35%	192 $44,000
Q1 2024 May 10, 2024	SELL	$233.45 - $247.73 $608,370 - $645,584	-2,606 Reduced 93.41%	184 $45,000
Q4 2023 Feb 14, 2024	SELL	$232.24 - $267.23 $935,230 - $1.08 Million	-4,027 Reduced 59.07%	2,790 $680,000
Q3 2023 Nov 13, 2023	BUY	$254.9 - $283.59 $91,509 - $101,808	359 Added 5.56%	6,817 $1.76 Million
Q2 2023 Dec 13, 2023	BUY	$238.39 - $265.32 $27,176 - $30,246	114 Added 1.8%	6,458 $1.7 Million
Q2 2023 Aug 10, 2023	BUY	$238.39 - $265.32 $27,176 - $30,246	114 Added 1.8%	6,458 $1.7 Million
Q1 2023 Dec 13, 2023	SELL	$229.71 - $259.35 $4,594 - $5,187	-20 Reduced 0.31%	6,344 $1.57 Million
Q1 2023 May 12, 2023	SELL	$229.71 - $259.35 $4,594 - $5,187	-20 Reduced 0.31%	6,344 $1.57 Million
Q4 2022 Dec 13, 2023	BUY	$218.29 - $256.91 $288,579 - $339,635	1,322 Added 26.22%	6,364 $1.62 Million
Q4 2022 Feb 10, 2023	BUY	$218.29 - $256.91 $288,579 - $339,635	1,322 Added 26.22%	6,364 $1.62 Million
Q3 2022 Dec 13, 2023	BUY	$51.03 - $264.23 $5,051 - $26,158	99 Added 2.0%	5,042 $1.12 Million
Q3 2022 Nov 08, 2022	BUY	$51.03 - $264.23 $5,051 - $26,158	99 Added 2.0%	5,042 $1.12 Million
Q2 2022 Dec 13, 2023	BUY	$234.74 - $275.42 $489,667 - $574,526	2,086 Added 73.01%	4,943 $1.22 Million
Q2 2022 Aug 15, 2022	BUY	$234.74 - $275.42 $489,667 - $574,526	2,086 Added 73.01%	4,943 $1.22 Million
Q1 2022 Dec 13, 2023	SELL	$243.64 - $270.48 $964,814 - $1.07 Million	-3,960 Reduced 58.09%	2,857 $741,000
Q1 2022 May 17, 2022	BUY	$243.64 - $270.48 $696,079 - $772,761	2,857 New	2,857 $706,000
Q1 2020 May 18, 2021	SELL	$195.69 - $279.01 $175,729 - $250,550	-898 Closed	0 $0
Q4 2019 May 17, 2021	SELL	$236.45 - $266.82 $37,832 - $42,691	-160 Reduced 15.12%	898 $244,000
Q3 2019 May 18, 2021	BUY	$230.58 - $256.08 $48,421 - $53,776	210 Added 24.76%	1,058 $265,000
Q2 2019 May 18, 2021	BUY	$217.4 - $246.08 $184,355 - $208,675	848 New	848 $216,000

Others Institutions Holding BDX

# of Institutions

1,739

Shares Held

260M

Call Options Held

1.82M

Put Options Held

696K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $54.9B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Continuum Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Continuum Advisory, LLC with notifications on news.

Account

Continuum Advisory, LLC Becton Dickinson & CO Transaction History